Literature DB >> 17957439

Sclerosing cholangitis epidemiology and etiology.

Konstantinos N Lazaridis1.   

Abstract

Sclerosing cholangitis represents a spectrum of chronic biliary diseases that either has an unknown etiology (i.e., primary) or is caused by identifiable insults to the biliary tree (i.e., secondary). To date, the epidemiology of primary sclerosing cholangitis has been appraised; however, its etiology continues to be unclear. In contrast, the etiology of secondary sclerosing cholangitis is always known, but the epidemiology of this clinical entity is difficult to study.

Entities:  

Mesh:

Year:  2007        PMID: 17957439     DOI: 10.1007/s11605-007-0344-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  20 in total

1.  A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.

Authors:  J Satsangi; R W Chapman; N Haldar; P Donaldson; S Mitchell; J Simmons; S Norris; S E Marshall; J I Bell; D P Jewell; K I Welsh
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.

Authors:  R Eri; J R Jonsson; N Pandeya; D M Purdie; A D Clouston; N Martin; D Duffy; E E Powell; J Fawcett; T H J Florin; G L Radford-Smith
Journal:  Genes Immun       Date:  2004-09       Impact factor: 2.676

3.  Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.

Authors:  Andrea A Gossard; Paul Angulo; Keith D Lindor
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

4.  Familial occurrence of primary sclerosing cholangitis and ulcerative colitis.

Authors:  E M Quigley; N F LaRusso; J Ludwig; R N MacSween; G G Birnie; G Watkinson
Journal:  Gastroenterology       Date:  1983-11       Impact factor: 22.682

5.  Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis.

Authors:  J Ludwig; S S Barham; N F LaRusso; L R Elveback; R H Wiesner; J T McCall
Journal:  Hepatology       Date:  1981 Nov-Dec       Impact factor: 17.425

6.  Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.

Authors:  Kiran Bambha; W Ray Kim; Jayant Talwalkar; Heidi Torgerson; Joanne T Benson; Terry M Therneau; Edward V Loftus; Barbara P Yawn; E Rolland Dickson; L Joseph Melton
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

7.  Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.

Authors:  P Muratori; L Muratori; M Guidi; S Maccariello; G Pappas; R Ferrari; P Gionchetti; M Campieri; F B Bianchi
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

8.  Association of primary sclerosing cholangitis with HLA-B8.

Authors:  R W Chapman; Z Varghese; R Gaul; G Patel; N Kokinon; S Sherlock
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

9.  Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery.

Authors:  K R Palmer; B I Duerden; C D Holdsworth
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

10.  Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.

Authors:  Xuesong Yang; Susan N Cullen; Jin H Li; Roger W Chapman; Derek P Jewell
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

View more
  4 in total

Review 1.  Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.

Authors:  Mario Strazzabosco; Romina Fiorotto; Massimiliano Cadamuro; Carlo Spirli; Valeria Mariotti; Eleanna Kaffe; Roberto Scirpo; Luca Fabris
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-25       Impact factor: 5.187

2.  Isolated Mass-Forming IgG4-Related Cholangitis as an Initial Clinical Presentation of Systemic IgG4-Related Disease.

Authors:  Seokhwi Kim; Hyunsik Bae; Misun Choi; Binnari Kim; Jin Seok Heo; Ho Seong Kim; Seung Hee Choi; Kee-Taek Jang
Journal:  J Pathol Transl Med       Date:  2016-01-11

3.  Secondary sclerosing cholangitis as a complication of severe COVID-19: A case report and review of the literature.

Authors:  Caroline Klindt; Björn-Erik Jensen; Timo Brandenburger; Torsten Feldt; Alexander Killer; Lars Schimmöller; Gerald Antoch; Tina Senff; Sandra Hauka; Jörg Timm; Bahne Hendrik Bahners; Maximilian Seidl; Irene Esposito; Tom Luedde; Johannes G Bode; Verena Keitel
Journal:  Clin Case Rep       Date:  2021-05-24

4.  Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies.

Authors:  Jan Best; Stefaan Verhulst; Wing-Kin Syn; Kimberly Lagaisse; Noemi van Hul; Femke Heindryckx; Jan-Peter Sowa; Liesbeth Peeters; Hans Van Vlierberghe; Isabelle A Leclercq; Ali Canbay; Laurent Dollé; Leo A van Grunsven
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.